Implementing Best Practices in the Management of Allergic Diseases

Slides:

Advertisements

Similar presentations

Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.

Advertisements

Authors: Petersen KD §1, Kronborg C 2, Beck SJ 3, Larsen JN 4, Dahl R 5, Gyrd-Hansen D 2, 6 §1 Corresponding: Karin Dam Petersen, Danish Centre for Healthcare.

Allergy Allergy is caused by an improper reaction of our immune system to certain factors. There are two basic types of hypersensitiveness: -early type.

SLIT: dealing with trouble, doing it right. Giovanni B Pajno MD Professor of Pediatrics Department of Pediatrics – Allergy Unit University of Messina Italy.

Sublingual Allergy Treatment. Sublingual Immunotherapy Immunotherapy is widely used by allergy specialists because it treats the underlying cause of allergic.

Where Are We on the Path to Elimination of Chronic Hepatitis C?

Upfront Combination Therapy vs Step-Up Approach for PAH:

Food Allergies: Diagnosis & Management

An Interprofessional Approach to Optimizing Patient Care in Allergy

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Clinical Developments in Allergen Immunotherapy

Chronic Hepatitis C Virus Infection

RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL

Starting Strong: Initial Evaluation of the Patient With HCV

Allergy Testing in Children

New Patient Journeys in Non-small cell lung cancer

Progression After Cancer Immunotherapy in Advanced NSCLC

Spotlight on Immuno-Oncology in Melanoma

The Latest Data on Oral Prostacyclin Therapy in PAH

Clinical Review.

Seasonal Allergic Rhinitis

SGLT2 Inhibitors in the Modern Era: Why and Where?

Program Goals. Program Goals What is Atopic Dermatitis?

Tailoring Hemophilia Prophylaxis Therapy

Addressing Disease Burden in Asthma

A Focus on Polycythemia Vera for Nurse Practitioners and Physician Assistants.

Talking to Patients About Diabetes Management

Treatment Options to Consider

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer.

Patient Case: KC. Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective.

The Future of House Dust Mite Allergy

Advances in Peanut Allergen Immunotherapy

Gene Therapy: Past, Present, and Future

Immunotherapy for cSCC

EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.

When Is Biologic Therapy Appropriate for HS?

In-Depth Discussion of Key Data on Immunotherapy for Allergic Diseases

Staying Abreast of Best Practices Across the Clinical Continuum

Oral Prostanoids and PAH

Program Goals Overview Is NEDA a Reasonable Target?

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

The Road to Quality Improvement in HER2-Positive Breast Cancer

Identifying Strategies for Improving Outcomes in Patients With CTEPH

Prolonging the Effects of Factor IX Replacement Therapy in Hemophilia B.

Managing Age-Related Clinical Issues in Hemophilia

Are We Making Progress in the Management of Huntington Disease?

The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.

Improving Adherence to Antiplatelet Therapy After an ACS Event

Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators

The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.

Assessing the Burden of Hyperkalemia

Program Goal. Program Goal Disclaimer Overview.

Program Goals Overview Is NEDA a Reasonable Target?

Peanut Allergy Immunotherapy

AMD Therapy: Where Are We Now and Where Are We Going?

Assessing the Burden of Hyperkalemia

Peanut Allergy Immunotherapy

Children's compliance with allergen immunotherapy according to administration routes Giovanni Battista Pajno, MD, Daniela Vita, MD, Lucia Caminiti, MD,

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Evaluating Success of Current Treatments for HCM

Championing Evidence-Based Care in Patients With Acute Low Back Pain

What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer

Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.

Exploring the Use of Adeno-Associated Virus for Gene Therapy

Which Patients for SLIT?

Fig. 4. The expression of TRAF6 in the PBMCs of the AR children after a 3-month SIT treatment. (A) Representative Western blot analysis of TRAF6 in the.

Navigating the Journey

Management of NTM Lung Disease

Presentation transcript:

Implementing Best Practices in the Management of Allergic Diseases

Overview

Typical Presentation of Allergic Rhinoconjunctivitis in Children

Physical Findings

Diagnostic Testing

Threefold Approach to Treatment

Additional Therapies

When to Consider Discussing Allergen Immunotherapy With Parents or Caregivers

How Does Location Affect the Diagnostic Evaluation?

Discussing Therapies With Patients (or Parents)

When to Consider Allergen Immunotherapy

SCIT

SLIT

Recent SLIT Studies

Potential Benefits of SLIT

Barriers to the Use of SCIT

Prevalence of Severe Systemic Reactions to SCIT

Contraindications to Allergen Immunotherapya

Candidates for Allergen Immunotherapya

Candidates for Allergen Immunotherapya (cont)

Abbreviations

References

References (cont)

References (cont)

References (cont)